PATENT CLAIM ANALYSIS

Application Number: 15950539
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "489000"]

Abstract:
The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.

Claim (Index 24):
An injectable, nanoparticulate pharmaceutical dosage form consisting of:\n 15 mg, 30 mg, or 60 mg of meloxicam, or a salt thereof, wherein the meloxicam is in the form of particles having an effective average particle size of less than about 100 nm; polyvinylpyrrolidone; sodium deoxycholate; sucrose; and water; wherein the composition comprises i) no more than 6,000 particles that are greater than 10 \u03bcm in size, and ii) no more than 600 particles that are greater than 25 \u03bcm in size.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 91.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15437534', '15950367', '10784900', '15130255', '15130331']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7903422369178545
- 35 USC 102 Novelty (BERT): 0.5292695293217543
- Combined Prediction Score: 0.7642349661582445
- Mean Citation Score: 310.536418
- Max Citation Score: 365.674
- Similarity Product: 260.1908437745571

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test